Difficulty: Medium
Average Score: 67%
Practice
A 63-year-old woman is hospitalized in the intensive care unit with overwhelming sepsis. She is on multiple intravenous medications and is now begun on imipenem/cilastatin. The treating physician must be concerned about which of the following side effects of this therapy?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Renal failure. Imipenem/cilastatin is a broad-spectrum antibiotic that can cause nephrotoxicity, especially in patients who are critically ill and receiving multiple medications. The kidneys are responsible for clearing most drugs from the body, and certain antibiotics can be particularly harmful to renal function. In the case of this 63-year-old woman with overwhelming sepsis, her kidneys may already be compromised due to the septic shock, making them more vulnerable to drug-induced damage.
Option A) Cardiotoxicity is not typically associated with imipenem/cilastatin therapy. Option B) Gastrointestinal ischemia is not a common side effect of this antibiotic. Option C) Pulmonary fibrosis is not a known side effect of imipenem/cilastatin.
Educationally, it is crucial for healthcare professionals to be aware of the potential side effects of medications, especially in critically ill patients who are already at high risk for complications. Understanding the potential nephrotoxic effects of antibiotics like imipenem/cilastatin can help clinicians monitor patients closely, adjust dosages, or consider alternative therapies to prevent harm to the kidneys. Monitoring renal function through lab tests and assessing for signs of renal failure are essential practices in managing patients on potentially nephrotoxic medications, particularly in the intensive care setting.
Option A) Cardiotoxicity is not typically associated with imipenem/cilastatin therapy. Option B) Gastrointestinal ischemia is not a common side effect of this antibiotic. Option C) Pulmonary fibrosis is not a known side effect of imipenem/cilastatin.
Educationally, it is crucial for healthcare professionals to be aware of the potential side effects of medications, especially in critically ill patients who are already at high risk for complications. Understanding the potential nephrotoxic effects of antibiotics like imipenem/cilastatin can help clinicians monitor patients closely, adjust dosages, or consider alternative therapies to prevent harm to the kidneys. Monitoring renal function through lab tests and assessing for signs of renal failure are essential practices in managing patients on potentially nephrotoxic medications, particularly in the intensive care setting.